Overview
Mengyun Li practices practicing medicine in Suzhou, China.
Their clinical expertise encompasses Adult T-Cell Leukemia, Leukemia, Acute Lymphoblastic Leukemia (ALL), and Acute Myeloid Leukemia (AML).
They are actively involved in clinical research, co-authoring 13 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Mengyun Li
Is Mengyun Li a top-rated expert for Adult T-Cell Leukemia?
MediFind is an objective health platform that identifies experts based on real-world data. Mengyun Li is classified as an Experienced expert for Adult T-Cell Leukemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Mengyun Li participate in research or clinical trials?
Yes. Mengyun Li has published 13 articles and abstracts on conditions like Adult T-Cell Leukemia. You can view a list of Mengyun Li's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Lymphoblastic Leukemia (ALL)
- Acute Myeloid Leukemia (AML)
- Adult T-Cell LeukemiaLi isExperienced. Learn about Adult T-Cell Leukemia.
- LeukemiaLi isExperienced. Learn about Leukemia.
- Neurotoxicity SyndromesLi isExperienced. Learn about Neurotoxicity Syndromes.